+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Systemic Psoriasis Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 213 Pages
  • October 2024
  • Region: Global
  • TechNavio
  • ID: 6031007
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The systemic psoriasis therapeutics market is forecasted to grow by USD 18.06 billion during 2023-2028, accelerating at a CAGR of 16.2% during the forecast period. The report on the systemic psoriasis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of psoriasis, investments in development of psoriasis therapeutics, and presence of psoriasis therapeutics in pipeline.

The systemic psoriasis therapeutics market is segmented as below:

By End-user

  • Hospitals
  • Retail pharmacies

By Product

  • Biologics
  • Small molecules

By Route Of Administration

  • Oral
  • Parenteral

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the use of phototherapy to treat systemic psoriasis as one of the prime reasons driving the systemic psoriasis therapeutics market growth during the next few years. Also, introduction of systematic oral therapeutics and strategic partnerships among vendors will lead to sizable demand in the market.

The report on the systemic psoriasis therapeutics market covers the following areas:

  • Systemic Psoriasis Therapeutics Market sizing
  • Systemic Psoriasis Therapeutics Market forecast
  • Systemic Psoriasis Therapeutics Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading systemic psoriasis therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc. Also, the systemic psoriasis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value Chain Analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Systemic Psoriasis Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Systemic Psoriasis Therapeutics Market 2018 - 2022 ($ million)
5.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
5.3 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
5.4 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
5.5 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.6 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Systemic Psoriasis Therapeutics Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by End-user
8.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
8.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2023-2028
Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
8.4 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
8.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
9 Market Segmentation by Product
9.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
9.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
9.3 Biologics - Market size and forecast 2023-2028
Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Chart on Biologics - Year-over-year growth 2023-2028 (%)
Data Table on Biologics - Year-over-year growth 2023-2028 (%)
9.4 Small molecules - Market size and forecast 2023-2028
Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
9.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
10.4 Parenteral - Market size and forecast 2023-2028
Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
10.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
12.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
12.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
12.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
12.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
12.8 Norway - Market size and forecast 2023-2028
Chart on Norway - Market size and forecast 2023-2028 ($ million)
Data Table on Norway - Market size and forecast 2023-2028 ($ million)
Chart on Norway - Year-over-year growth 2023-2028 (%)
Data Table on Norway - Year-over-year growth 2023-2028 (%)
12.9 Kazakhstan - Market size and forecast 2023-2028
Chart on Kazakhstan - Market size and forecast 2023-2028 ($ million)
Data Table on Kazakhstan - Market size and forecast 2023-2028 ($ million)
Chart on Kazakhstan - Year-over-year growth 2023-2028 (%)
Data Table on Kazakhstan - Year-over-year growth 2023-2028 (%)
12.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
12.11 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
12.12 Philippines - Market size and forecast 2023-2028
Chart on Philippines - Market size and forecast 2023-2028 ($ million)
Data Table on Philippines - Market size and forecast 2023-2028 ($ million)
Chart on Philippines - Year-over-year growth 2023-2028 (%)
Data Table on Philippines - Year-over-year growth 2023-2028 (%)
12.13 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
12.14 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
12.15 Brazil - Market size and forecast 2023-2028
Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Chart on Brazil - Year-over-year growth 2023-2028 (%)
Data Table on Brazil - Year-over-year growth 2023-2028 (%)
12.16 Spain - Market size and forecast 2023-2028
Chart on Spain - Market size and forecast 2023-2028 ($ million)
Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Chart on Spain - Year-over-year growth 2023-2028 (%)
Data Table on Spain - Year-over-year growth 2023-2028 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.7 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
SWOT
15.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.9 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
15.11 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.12 LEO Pharma AS
LEO Pharma AS - Overview
LEO Pharma AS - Business segments
LEO Pharma AS - Key offerings
LEO Pharma AS - Segment focus
SWOT
15.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.17 UCB SA
UCB SA - Overview
UCB SA - Product / Service
UCB SA - Key offerings
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2023 and 2028
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value Chain Analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 25: Historic Market Size - Data Table on Global Systemic Psoriasis Therapeutics Market 2018 - 2022 ($ million)
Exhibits 26: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 27: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 28: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2023 and 2028
Exhibits 32: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 34: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 35: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 36: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 37: Chart on Market condition - Five forces 2023 and 2028
Exhibits 38: Chart on End-user - Market share 2023-2028 (%)
Exhibits 39: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 40: Chart on Comparison by End-user
Exhibits 41: Data Table on Comparison by End-user
Exhibits 42: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 46: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 47: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits 48: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 49: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits 50: Market opportunity by End-user ($ million)
Exhibits 51: Data Table on Market opportunity by End-user ($ million)
Exhibits 52: Chart on Product - Market share 2023-2028 (%)
Exhibits 53: Data Table on Product - Market share 2023-2028 (%)
Exhibits 54: Chart on Comparison by Product
Exhibits 55: Data Table on Comparison by Product
Exhibits 56: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits 64: Market opportunity by Product ($ million)
Exhibits 65: Data Table on Market opportunity by Product ($ million)
Exhibits 66: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 67: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 68: Chart on Comparison by Route of Administration
Exhibits 69: Data Table on Comparison by Route of Administration
Exhibits 70: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 73: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 74: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 77: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits 78: Market opportunity by Route of Administration ($ million)
Exhibits 79: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 81: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 83: Chart on Geographic comparison
Exhibits 84: Data Table on Geographic comparison
Exhibits 85: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Norway - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Norway - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Norway - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Norway - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Kazakhstan - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Kazakhstan - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Kazakhstan - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Kazakhstan - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 115: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 117: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 118: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 119: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 120: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 121: Chart on Philippines - Market size and forecast 2023-2028 ($ million)
Exhibits 122: Data Table on Philippines - Market size and forecast 2023-2028 ($ million)
Exhibits 123: Chart on Philippines - Year-over-year growth 2023-2028 (%)
Exhibits 124: Data Table on Philippines - Year-over-year growth 2023-2028 (%)
Exhibits 125: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 126: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 127: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 128: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 130: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 131: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 133: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits 134: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits 135: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 136: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 137: Chart on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 138: Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 139: Chart on Spain - Year-over-year growth 2023-2028 (%)
Exhibits 140: Data Table on Spain - Year-over-year growth 2023-2028 (%)
Exhibits 141: Market opportunity By Geographical Landscape ($ million)
Exhibits 142: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 143: Impact of drivers and challenges in 2023 and 2028
Exhibits 144: Overview on criticality of inputs and factors of differentiation
Exhibits 145: Overview on factors of disruption
Exhibits 146: Impact of key risks on business
Exhibits 147: Companies covered
Exhibits 148: Company ranking index
Exhibits 149: Matrix on companies position and classification
Exhibits 150: AbbVie Inc. - Overview
Exhibits 151: AbbVie Inc. - Product / Service
Exhibits 152: AbbVie Inc. - Key news
Exhibits 153: AbbVie Inc. - Key offerings
Exhibits 154: SWOT
Exhibits 155: Amgen Inc. - Overview
Exhibits 156: Amgen Inc. - Product / Service
Exhibits 157: Amgen Inc. - Key news
Exhibits 158: Amgen Inc. - Key offerings
Exhibits 159: SWOT
Exhibits 160: AstraZeneca Plc - Overview
Exhibits 161: AstraZeneca Plc - Product / Service
Exhibits 162: AstraZeneca Plc - Key news
Exhibits 163: AstraZeneca Plc - Key offerings
Exhibits 164: SWOT
Exhibits 165: Bausch Health Companies Inc. - Overview
Exhibits 166: Bausch Health Companies Inc. - Business segments
Exhibits 167: Bausch Health Companies Inc. - Key news
Exhibits 168: Bausch Health Companies Inc. - Key offerings
Exhibits 169: Bausch Health Companies Inc. - Segment focus
Exhibits 170: SWOT
Exhibits 171: Boehringer Ingelheim International GmbH - Overview
Exhibits 172: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 173: Boehringer Ingelheim International GmbH - Key news
Exhibits 174: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 175: SWOT
Exhibits 176: Bristol Myers Squibb Co. - Overview
Exhibits 177: Bristol Myers Squibb Co. - Product / Service
Exhibits 178: Bristol Myers Squibb Co. - Key news
Exhibits 179: Bristol Myers Squibb Co. - Key offerings
Exhibits 180: SWOT
Exhibits 181: Eli Lilly and Co. - Overview
Exhibits 182: Eli Lilly and Co. - Product / Service
Exhibits 183: Eli Lilly and Co. - Key offerings
Exhibits 184: SWOT
Exhibits 185: Johnson and Johnson Services Inc. - Overview
Exhibits 186: Johnson and Johnson Services Inc. - Business segments
Exhibits 187: Johnson and Johnson Services Inc. - Key news
Exhibits 188: Johnson and Johnson Services Inc. - Key offerings
Exhibits 189: Johnson and Johnson Services Inc. - Segment focus
Exhibits 190: SWOT
Exhibits 191: LEO Pharma AS - Overview
Exhibits 192: LEO Pharma AS - Business segments
Exhibits 193: LEO Pharma AS - Key offerings
Exhibits 194: LEO Pharma AS - Segment focus
Exhibits 195: SWOT
Exhibits 196: Merck and Co. Inc. - Overview
Exhibits 197: Merck and Co. Inc. - Business segments
Exhibits 198: Merck and Co. Inc. - Key news
Exhibits 199: Merck and Co. Inc. - Key offerings
Exhibits 200: Merck and Co. Inc. - Segment focus
Exhibits 201: SWOT
Exhibits 202: Novartis AG - Overview
Exhibits 203: Novartis AG - Business segments
Exhibits 204: Novartis AG - Key news
Exhibits 205: Novartis AG - Key offerings
Exhibits 206: Novartis AG - Segment focus
Exhibits 207: SWOT
Exhibits 208: Pfizer Inc. - Overview
Exhibits 209: Pfizer Inc. - Product / Service
Exhibits 210: Pfizer Inc. - Key news
Exhibits 211: Pfizer Inc. - Key offerings
Exhibits 212: SWOT
Exhibits 213: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 214: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 215: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 216: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 217: SWOT
Exhibits 218: UCB SA - Overview
Exhibits 219: UCB SA - Product / Service
Exhibits 220: UCB SA - Key offerings
Exhibits 221: SWOT
Exhibits 222: Viatris Inc. - Overview
Exhibits 223: Viatris Inc. - Business segments
Exhibits 224: Viatris Inc. - Key news
Exhibits 225: Viatris Inc. - Key offerings
Exhibits 226: Viatris Inc. - Segment focus
Exhibits 227: SWOT
Exhibits 228: Inclusions checklist
Exhibits 229: Exclusions checklist
Exhibits 230: Currency conversion rates for US$
Exhibits 231: Research methodology
Exhibits 232: Information sources
Exhibits 233: Data validation
Exhibits 234: Validation techniques employed for market sizing
Exhibits 235: Data synthesis
Exhibits 236: 360 degree market analysis
Exhibits 237: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global systemic psoriasis therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is use of phototherapy to treat systemic psoriasis."

According to the report, one of the major drivers for this market is the rising incidence of psoriasis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bausch Health Companies Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • LEO Pharma AS
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • UCB SA
  • Viatris Inc.

Related Topics

Related Reports

Psoriasis Drugs Market by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Psoriasis Drugs Market by Therapeutic Class, Type of Treatment, Mechanism of Action, Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Psoriasis Therapeutics Market by Molecule, Route of Administration, Dosage Forms, Mechanism of Action - Global Forecast 2025-2030 - Product Image

Psoriasis Therapeutics Market by Molecule, Route of Administration, Dosage Forms, Mechanism of Action - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Hydrocortisone Global Market Report 2024 - Product Image

Hydrocortisone Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Psoriasis Drugs Market - Product Image

Psoriasis Drugs Market

  • Report
  • 200 Pages
  • Global
From
Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region - Product Image

Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.